1 |
Williams E, Jenney AW, Spelman DW. Nocardia bacteremia: A single-center retrospective review and a systematic review of the literature[J]. Int J Infect Dis, 2020, 92: 197-207.
|
2 |
Tan YE, Chen SC, Halliday CL. Antimicrobial susceptibility profiles and species distribution of medically relevant Nocardia species: Results from a large tertiary laboratory in Australia[J]. J Glob Antimicrob Resist, 2020, 20: 110-117.
|
3 |
Woods GL, Brown-Elliott BA, Conville PS, et al. Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes [Internet]. 2nd ed. Wayne (PA): Clinical and Laboratory Standards Institute; 2011 Mar. Report No.: M24-A2. PMID: 31339680.
|
4 |
Wadhwa T, Baveja U, Kumar N, et al. Clinical manifestations of nocardiosis: study of risk factors and outcomes in a tertiary care hospital[J]. J Lab Physicians, 2017, 9(4): 288-295.
|
5 |
Ott SR, Meier N, Kolditz M, et al. OPINION Study Group. Pulmonary nocardiosis in Western Europe-Clinical evaluation of 43 patients and population-based estimates of hospitalization rates[J]. Int J Infect Dis, 2019, 81: 140-148.
|
6 |
高佳男, 张梦, 常静侠. 诺卡菌病34例临床分析[J]. 中国感染与化疗杂志, 2022, 22(3): 301-306.
|
7 |
Hamdi AM, Fida M, Deml SM, et al. Retrospective analysis of antimicrobial susceptibility profile66s of nocardia species from a tertiary hospital and reference laboratory, 2011 to 2017[J]. Antimicrob Agents Chemother, 2020, 64(3): e01868-19.
|
8 |
Farooqui F, Irfan S, Shakoor S, et al. Antimicrobial susceptibility and clinical characteristics of Nocardia isolates from a tertiary care centre diagnostic laboratory in Pakistan[J]. J Glob Antimicrob Resist, 2018, 15: 219-221.
|
9 |
李晓冉, 吕晓菊. 中国西南地区诺卡菌感染患者的临床特征分析[J]. 中国感染与化疗杂志, 2023, 23(1): 1-7.
|
10 |
Wang H, Zhu Y, Cui Q, et al. Epidemiology and Antimicrobial Resistance Profiles of the Nocardia Species in China, 2009 to 2021[J]. Microbiol Spectr, 2022, 10(2): e0156021.
|
11 |
李凤玉, 邓静敏. 肺诺卡菌病诊治的研究进展[J/OL]. 中华临床医师杂志(电子版), 2020, 14(10): 848-852.
|
12 |
武文明, 崔巧珍, 时东彦, 等. 39株诺卡菌的临床疾病特点及药敏结果分析[J]. 中国抗生素杂志, 2022, 47(12): 1326-1330.
|
13 |
Davidson N, Grigg MJ, Mcguinness SL, et al. Safety and outcomes of linezolid use for nocardiosis[J]. Open Forum Infect Dis, 2020, 7(4): ofaa090.
|
14 |
Restrepo A, Clark NM; Infectious Diseases Community of Practice of the American Society of Transplantation. Nocardia infections in solid organ transplantation: Guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation[J]. Clin Transplant, 2019, 33(9): e13509.
|
15 |
Lebeaux D, Freund R, van Delden C, et al. European Study Group for Nocardia in Solid Organ Transplantation; European Study Group for Nocardia in Solid Organ Transplantation. Outcome and treatment of nocardiosis after solid organ transplantation: new insights from a European study[J]. Clin Infect Dis, 2017, 64(10): 1396-1405.
|